Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention per Inouye, M, Abraham, G, Nelson, C, Wood, A, Sweeting, M, Dudbridge, F, Lai, F, Kaptoge, S, Brozynska, M, Wang, T, Ye, S, Webb, T, Rutter, M, Tzoulaki, I, Patel, R, Loos, R, Keavney, B, Hemingway, H, Thompson, J, Watkins, H, Deloukas, P, Di Angelantonio, E, Butterworth, A, Danesh, J, Samani, N, UK Biobank CardioMetabolic Consortium CHD Working Group

Association analyses based on false discovery rate implicate new loci for coronary artery disease per Nelson, CP, Goel, A, Butterworth, AS, Kanoni, S, Webb, TR, Marouli, E, Zeng, L, Ntalla, I, Lai, FY, Hopewell, JC, Giannakopoulou, O, Jiang, T, Hamby, SE, Di Angelantonio, E, Assimes, TL, Bottinger, EP, Chambers, JC, Clarke, R, Palmer, CNA, Cubbon, RM, Ellinor, P, Ermel, R, Evangelou, E, Franks, PW, Grace, C, Gu, D, Hingorani, AD, Howson, JMM, Ingelsson, E, Kastrati, A, Kessler, T, Kyriakou, T, Lehtimäki, T, Lu, X, Lu, Y, März, W, McPherson, R, Metspalu, A, Pujades-Rodriguez, M, Ruusalepp, A, Schadt, EE, Schmidt, AF, Sweeting, MJ, Zalloua, PA, AlGhalayini, K, Keavney, BD, Kooner, JS, Loos, RJF, Patel, RS, Rutter, MK, Tomaszewski, M, Tzoulaki, I, Zeggini, E, Erdmann, J, Dedoussis, G, Björkegren, JLM, EPIC-CVD Consortium, CARDIoGRAMplusC4D, UK Biobank CardioMetabolic Consortium CHD working group, Schunkert, H, Farrall, M, Danesh, J, Samani, NJ, Watkins, H, Deloukas, P